Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Zealand Pharma - Filing #1440145

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
8,977,000 DKK
0 DKK
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
342,261,000 DKK
172,464,000 DKK
Current assets
1,419,688,000 DKK
1,427,050,000 DKK
Non-current liabilities
177,378,000 DKK
161,707,000 DKK
Current liabilities
355,260,000 DKK
195,134,000 DKK
Revenue
353,314,000 DKK
41,333,000 DKK
37,977,000 DKK
Profit (loss)
846,729,000 DKK
0 DKK
846,729,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
571,541,000 DKK
571,541,000 DKK
0 DKK
0 DKK
0 DKK
581,278,000 DKK
581,278,000 DKK
0 DKK
Other comprehensive income
0 DKK
0 DKK
8,977,000 DKK
8,977,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
Comprehensive income
837,752,000 DKK
571,541,000 DKK
581,278,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.